En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este tercer día en el ACC 2026 de Nueva Orleans.

1. Redo-Surgery Versus Transcatheter Valve-In-Valve For Mitral Bioprosthetic Dysfunction: The SURVIV Trial

2. The Heartline Experience: Achieving Long-Term Participant Engagement in Digital Health Technology Trials

3. Effect Of Anti-fibrotic Therapy On Regression Of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) In Aortic Stenosis Patients With High Fibrotic Burden: The Reduce-MFA DZHK 25-trial